Osteonecrosis of the jaw from bone anti-resorptives: impact of skeletal site-dependent mesenchymal stem cells.
作者信息
Akintoye So
机构信息
School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.
出版信息
Oral Dis. 2014 Mar;20(2):221-2. doi: 10.1111/odi.12181. Epub 2013 Oct 7.
Abstract
摘要
相似文献
1
Osteonecrosis of the jaw from bone anti-resorptives: impact of skeletal site-dependent mesenchymal stem cells.
Oral Dis. 2014 Mar;20(2):221-2. doi: 10.1111/odi.12181. Epub 2013 Oct 7.
2
Mesenchymal stem cells and bisphosphonate-related osteonecrosis of the jaw: the future?
Oral Dis. 2012 Nov;18(8):823-4. doi: 10.1111/j.1601-0825.2012.01941.x. Epub 2012 Aug 23.
3
Hematopoietic stem cells and bisphosphonate-related osteonecrosis of the jaw.
Oral Dis. 2013 Jul;19(5):530. doi: 10.1111/odi.12056. Epub 2012 Dec 25.
4
Mesenchymal stromal cells administration for osteonecrosis of the jaw caused by bisphosphonate: report of two cases.
Acta Oncol. 2020 Jul;59(7):789-792. doi: 10.1080/0284186X.2020.1730004. Epub 2020 Feb 20.
5
Treatment of stage II medication-related osteonecrosis of the jaw with necrosectomy and autologous bone marrow mesenchymal stem cells.
Odontology. 2017 Oct;105(4):484-493. doi: 10.1007/s10266-017-0295-4. Epub 2017 Feb 20.
6
Multipotent mesenchymal stromal cell sheet therapy for bisphosphonate-related osteonecrosis of the jaw in a rat model.
Acta Biomater. 2016 Sep 15;42:400-410. doi: 10.1016/j.actbio.2016.06.022. Epub 2016 Jun 17.
7
Exosomes from Adipose-Derived Stem Cells Can Prevent Medication-Related Osteonecrosis of the Jaw.
Med Sci Monit. 2021 Mar 10;27:e929684. doi: 10.12659/MSM.929684.
8
Tetraparesis after surgical treatment of bisphosphonate-associated osteonecrosis of the jaw.
J Neurosurg Sci. 2018 Feb;62(1):97-99. doi: 10.23736/S0390-5616.16.03535-X. Epub 2016 Apr 8.
9
Adipose-derived stem cells prevent the onset of bisphosphonate-related osteonecrosis of the jaw through transforming growth factor β-1-mediated gingival wound healing.
Stem Cell Res Ther. 2019 Jun 13;10(1):169. doi: 10.1186/s13287-019-1277-y.
10
Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ).
J Craniomaxillofac Surg. 2015 Mar;43(2):290-3. doi: 10.1016/j.jcms.2014.11.014. Epub 2014 Nov 22.
引用本文的文献
1
Craniofacial disorders and dysplasias: Molecular, clinical, and management perspectives.
Bone Rep. 2024 Mar 1;20:101747. doi: 10.1016/j.bonr.2024.101747. eCollection 2024 Mar.
2
Application of Panoramic Radiography in the Detection of Osteopenia and Osteoporosis-Current State of the Art.
Curr Osteoporos Rep. 2023 Aug;21(4):354-359. doi: 10.1007/s11914-023-00807-5. Epub 2023 Jun 29.
3
Are drug-related dental management cautions in Lexicomp Online for Dentistry evidence-based? A systematic review of the literature.
Quintessence Int. 2019;50(9):754-761. doi: 10.3290/j.qi.a43090.
4
The bone regenerative capacity of canine mesenchymal stem cells is regulated by site-specific multilineage differentiation.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Feb;123(2):163-172. doi: 10.1016/j.oooo.2016.09.011. Epub 2016 Sep 28.
本文引用的文献
1
Allogeneic mesenchymal stem cell therapy for bisphosphonate-related jaw osteonecrosis in Swine.
Stem Cells Dev. 2013 Jul 15;22(14):2047-56. doi: 10.1089/scd.2012.0615. Epub 2013 Apr 6.
2
Hematopoietic stem cells and bisphosphonate-related osteonecrosis of the jaw.
Oral Dis. 2013 Jul;19(5):530. doi: 10.1111/odi.12056. Epub 2012 Dec 25.
3
Mesenchymal stem cells and bisphosphonate-related osteonecrosis of the jaw: the future?
Oral Dis. 2012 Nov;18(8):823-4. doi: 10.1111/j.1601-0825.2012.01941.x. Epub 2012 Aug 23.
4
Risks for jaw osteonecrosis drastically increases after 2 years of bisphosphonate therapy.
J Evid Based Dent Pract. 2012 Jun;12(2):116-8. doi: 10.1016/j.jebdp.2012.03.003.
5
A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Dec;112(6):777-82. doi: 10.1016/j.tripleo.2011.07.004. Epub 2011 Oct 14.
6
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw.
Head Face Med. 2011 Aug 17;7:16. doi: 10.1186/1746-160X-7-16.
7
Osteonecrosis of the jaw after zoledronic acid and denosumab treatment.
J Clin Oncol. 2011 Jun 10;29(17):e521-2; author reply e523-4. doi: 10.1200/JCO.2011.35.1551. Epub 2011 May 2.
8
Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study.
J Clin Oncol. 2010 Dec 10;28(35):5132-9. doi: 10.1200/JCO.2010.29.7101. Epub 2010 Nov 8.
9
Osteogenic potential of mandibular vs. long-bone marrow stromal cells.
J Dent Res. 2010 Nov;89(11):1293-8. doi: 10.1177/0022034510378427. Epub 2010 Sep 1.
10
Human bone marrow stromal cells display variable anatomic site-dependent response and recovery from irradiation.
Arch Oral Biol. 2010 May;55(5):358-64. doi: 10.1016/j.archoralbio.2010.03.010. Epub 2010 Apr 7.
Zotero 插件